Dolca Thomas
Director at Allakos Inc. (ALLK) since July 2023
Dolca Thomas has filed 9 insider reports with the SEC since June 2021, as director at Allakos Inc. (ALLK) and director at Chinook Therapeutics, Inc. (KDNY). Dolca Thomas made no open-market purchases or sales in the last 12 months. The latest filing, on May 15, 2025, reports sale back to the company at Allakos Inc. (ALLK).
- Filings
- 9
- Companies
- 2
- Bought on market
- $212K
- Sold on market
- None
Companies where Dolca Thomas is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince July 2023 | May 15, 2025 | ||||||
| Director | 0 | $212K | $21.22 | Aug 11, 2023 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- May 15, 2025ALLKSEC Form 4 filed by Director Thomas DolcaForm 4Sale back to the company
- May 24, 2024ALLKSEC Form 4 filed by Thomas DolcaForm 4Grant or award
- Aug 11, 2023KDNYSEC Form 4: Thomas Dolca returned 13,300 shares to the company, closing all direct ownership in the companyForm 4Sale back to the company
- Aug 1, 2023ALLKSEC Form 4 filed by Thomas DolcaForm 4Grant or award
- Jul 31, 2023ALLKDolca Thomas became an insiderForm 3New insider
- May 26, 2023KDNYSEC Form 4 filed by Thomas DolcaForm 4Exercise or conversion of a derivative
- Sep 2, 2022+$212KKDNYSEC Form 4: Thomas Dolca bought $212,194 worth of shares (10,000 units at $21.22)Form 4Open-market purchase
- May 26, 2022KDNYSEC Form 4 filed by Thomas DolcaForm 4Grant or award
Compare Dolca Thomas with
- Dolca Thomas vs Paul Edward Walker1 shared
- Dolca Thomas vs Adam Tomasi1 shared
- Dolca Thomas vs Harlan Baird Radford1 shared
- Dolca Thomas vs Amy L Ladd1 shared
- Dolca Thomas vs Steven P James1 shared
- Dolca Thomas vs Graham Neil Murray Hamilton1 shared
Other insiders at the same companies
- Bvf Partners L P/ilALLK
- Paul Edward WalkerALLK
- Adam TomasiALLK
- Harlan Baird RadfordALLK
- Amy L LaddALLK
- Steven P JamesALLK
- Graham Neil Murray HamiltonALLK
- Robert E AndreattaALLK
- Robert AlexanderALLK
- Chin Hyok LeeALLK
Questions about Dolca Thomas
- What is Dolca Thomas's role at Allakos Inc.?
- Dolca Thomas reports to the SEC as director at Allakos Inc. (ALLK), according to the latest filing on May 15, 2025. Dolca Thomas has also filed as director at Chinook Therapeutics, Inc. (KDNY).
- Has Dolca Thomas bought or sold stock recently?
- The most recent open-market purchase was on September 2, 2022: bought 10,000 shares of Chinook Therapeutics, Inc. (KDNY) for $212K at an average of $21.22.
- How do I get alerts when Dolca Thomas files?
- Follow Dolca Thomas on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Dolca Thomas (SEC CIK 0001768239). Totals count each trade once, skipping amendments whose original is on file, from Jun 8, 2021 on. View on SEC EDGAR · Get this as JSON